Form S-3 Contineum Therapeutics,

Go back to Form S-3 Contineum Therapeutics,

Contineum Therapeutics (CTNM) Files $300M Mixed Shelf

May 14, 2025 4:43 PM EDT

Contineum Therapeutics (NASDAQ: CTNM) has filed $300,000,000 mixed shelf of:

Class A Common Stock

Preferred Stock

Debt Securities

Warrants

Units

... More